Cancer Research Clinical Trials During the COVID-19 Pandemic
May, 2020 by Priscilla F. McAuliffe MD PhD, Beth Z. Clark MD, Jennifer M. Xavier PhD, Steffi Oesterreich PhD, Rachel C. Jankowitz MD The unprecedented...
ILC is understudied and poorly understood, and requires substantive measures to accelerate research.
Patients who are in cancer treatment, have undergone treatment or are living with lobular breast cancer can help advance our understanding of the disease by participating in clinical trials and research studies. Trials and studies that specifically include lobular breast cancer are hi-lighted below. Patients with lobular breast cancer can participate in many clinical trials, even if those trials are not specifically studying ILC. Find trials at at BreastCancerTrials.org or Clinicaltrials.gov.
Are you a patient research advocate and want to work with us to advance ILC research and grants?
Email info@lobularbreastcancer.org and introduce yourself! Learn more about Research Advocacy.
May, 2020 by Priscilla F. McAuliffe MD PhD, Beth Z. Clark MD, Jennifer M. Xavier PhD, Steffi Oesterreich PhD, Rachel C. Jankowitz MD The unprecedented...
Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligi...
Clinical Trials Improve Patient Care and Outcomes and advance critical research to improve our understanding of Invasive Lobular Breast Cancer...
The GELATO clinical trial is a lobular breast-cancer specific immunotherapy trial investigating the response to an immunotherapy + chemotherapy medica...
Research Priorities identified by Lobular Breast Cancer patient advocates...
Patients with Metastatic Lobular Breast Cancer (cancer has spread beyond the breast to other parts of the body) have a unique opportunity to advance c...
Women who have been diagnosed with Stage 1 - 3 invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible...
The ROLO trial is a targeted therapy clinical trial in the United Kingdom for patients with advanced or metastatic lobular breast cancer. Name of the ...